IPO Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Christer Rosen, Chairman and Chief Executive Officer, and Alison Silva, President and Chief Business Officer of Jupiter Neurosciences, Inc. (Nasdaq: JUNS). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the company’s treatments for neuroinflammation and rare diseases through JOTROL, its patented resveratrol delivery platform. They also talked about the company’s clinical pipeline with $50B+ com ...